|
|
(3 intermediate revisions by the same user not shown) |
Line 16: |
Line 16: |
|
| |
|
| =Text= | | =Text= |
| {{#Wiki_filter:Northwest Medical IsotopesConstruction Permit Application Review*Mandatory Hearing (Environmental Panel)*January 23, 2018 2Panelists*Benjamin Beasley-Chief, Environmental Review and NEPA Branch,NRR*Nancy Martinez-Physical Scientist,NRR*Michelle Moser-Biologist,NRR*David Drucker-Senior Project Manager,NRR2 EnvironmentalReview*National Environmental PolicyAct*Environmental reviewprocess-10 CFR Part51-Interim StaffGuidanceAugmenting NUREG-1537 for Licensing Radioisotope Production Facilities and Aqueous Homogenous Reactors3 Scope of the Review: Proposed Action and Connected ActionsActions are connected if they:-Automatically trigger other actions that may require environmental impact statements; or-Cannot or will not proceed unless other actions are taken previously or simultaneously; or-Are interdependent parts of a larger action and depend on the larger action for their justification4 Proposed Action and Connected Actions*Construction, operations, and decommissioning of the 10 CFR Part 50 production facility*Construction, operations, and decommissioning related to target fabrication*Transportation of targets to/from research reactors and irradiation of targets at research reactors5 6Environmental Impact Statement(EIS)*10 CFR51.20*Project-specificdecision-Operation of the proposed Northwest facility would include target fabrication and scrap recovery-Environmental assessment might not support a finding of no significant impact6 7ScopingProcess*Public meeting in Columbia, Missouri *Sixoralcommenters*Eightcomment letters or emails7 Environmental ReviewAreasHumanHealthTerrestrial ResourcesAirQualitySocioeconomics and EnvironmentalJusticeLandUseHistoric and CulturalResourcesWaterResourcesAquaticResourcesSoils8 EnvironmentalImpactsResourceAreaImpactLand Use and VisualResourcesSMALLAir Quality andNoiseSMALLGeologicEnvironmentSMALLEcological and WaterResourcesSMALLHistoric and CulturalResourcesSMALLSocioeconomicsSMALLHuman Health andWasteSMALLTransportationSMALL9 ConsultationsActDeterminationEndangeredSpecies Act, Section7No EffectNationalHistoric Preservation Act, Section 106No Adverse Effect10 Alternatives*No-actionalternative*Alternativesite*Alternative technologies11 AlternativeTechnologies*Neutroncapture*Aqueous homogenousreactor*Selective gas extraction*Linear-accelerator-based-Analyzed indepth*Subcritical fission-Analyzed indepth12 Costs andBenefits*Purpose-Inform recommendation to the Commission*Costs-Environmental andfinancial*Benefits-Societal, medical, andeconomic13 Draft Environmental Impact Statement*Public meeting in Columbia, Missouri*Seven oral commenters*Five comment letters or emails14 StaffConclusion and Recommendation*Benefits (societal, medical, and economic) outweigh the costs (environmental, economic)*Considered reasonable alternatives*Recommend issuance of the constructionpermit15 FutureNEPA Analyses*Application for an operating license*Application for a license to possess and use special nuclear material for target fabrication and scrap recovery*License amendment requests from research reactors16 Acronyms17*EIS -Environmental Impact Statement*NEPA -National Environmental Policy Act*NRR -Office of Nuclear Reactor Regulation | | {{#Wiki_filter:NRC-013 Northwest Medical Isotopes Construction Permit Application Review |
| }} | | * Mandatory Hearing (Environmental Panel) |
| | * January 23, 2018 |
| | |
| | Panelists |
| | * Benjamin Beasley |
| | - Chief, Environmental Review and NEPA Branch, NRR |
| | * Nancy Martinez |
| | - Physical Scientist, NRR |
| | * Michelle Moser |
| | - Biologist, NRR |
| | * David Drucker |
| | - Senior Project Manager, NRR 2 2 |
| | |
| | Environmental Review |
| | * National Environmental Policy Act |
| | * Environmental review process |
| | - 10 CFR Part 51 |
| | - Interim Staff Guidance Augmenting NUREG-1537 for Licensing Radioisotope Production Facilities and Aqueous Homogenous Reactors 3 |
| | |
| | Scope of the Review: Proposed Action and Connected Actions Actions are connected if they: |
| | - Automatically trigger other actions that may require environmental impact statements; or |
| | - Cannot or will not proceed unless other actions are taken previously or simultaneously; or |
| | - Are interdependent parts of a larger action and depend on the larger action for their justification 4 |
| | |
| | Proposed Action and Connected Actions |
| | * Construction, operations, and decommissioning of the 10 CFR Part 50 production facility |
| | * Construction, operations, and decommissioning related to target fabrication |
| | * Transportation of targets to/from research reactors and irradiation of targets at research reactors 5 |
| | |
| | Environmental Impact Statement (EIS) |
| | * 10 CFR 51.20 |
| | * Project-specific decision |
| | - Operation of the proposed Northwest facility would include target fabrication and scrap recovery |
| | - Environmental assessment might not support a finding of no significant impact 66 |
| | |
| | Scoping Process |
| | * Public meeting in Columbia, Missouri |
| | * Six oral commenters |
| | * Eight comment letters or emails 77 |
| | |
| | Environmental Review Areas Air Quality Socioeconomics and Environmental Terrestrial Justice Resources Human Health Aquatic Resources Land Use Water Soils Resources Historic and Cultural Resources 8 |
| | |
| | Environmental Impacts Resource Area Impact Land Use and Visual Resources SMALL Air Quality and Noise SMALL Geologic Environment SMALL Ecological and Water Resources SMALL Historic and Cultural Resources SMALL Socioeconomics SMALL Human Health and Waste SMALL Transportation SMALL 9 |
| | |
| | Consultations Act Determination Endangered Species Act, No Effect Section 7 National Historic No Adverse Preservation Act, Effect Section 106 10 |
| | |
| | Alternatives |
| | * No-action alternative |
| | * Alternative site |
| | * Alternative technologies 11 |
| | |
| | Alternative Technologies |
| | * Neutron capture |
| | * Aqueous homogenous reactor |
| | * Selective gas extraction |
| | * Linear-accelerator-based |
| | - Analyzed in depth |
| | * Subcritical fission |
| | - Analyzed in depth 12 |
| | |
| | Costs and Benefits |
| | * Purpose |
| | - Inform recommendation to the Commission |
| | * Costs |
| | - Environmental and financial |
| | * Benefits |
| | - Societal, medical, and economic 13 |
| | |
| | Draft Environmental Impact Statement |
| | * Public meeting in Columbia, Missouri |
| | * Seven oral commenters |
| | * Five comment letters or emails 14 |
| | |
| | Staff Conclusion and Recommendation |
| | * Benefits (societal, medical, and economic) outweigh the costs (environmental, economic) |
| | * Considered reasonable alternatives |
| | * Recommend issuance of the construction permit 15 |
| | |
| | Future NEPA Analyses |
| | * Application for an operating license |
| | * Application for a license to possess and use special nuclear material for target fabrication and scrap recovery |
| | * License amendment requests from research reactors 16 |
| | |
| | Acronyms |
| | * EIS - Environmental Impact Statement |
| | * NEPA - National Environmental Policy Act |
| | * NRR - Office of Nuclear Reactor Regulation 17}} |
|
---|
Category:Legal-Pre-Filed Exhibits
MONTHYEARML18037A8842018-02-0606 February 2018 Nwmi Commission Hearing Exhibit List - Revision 2 ML18037A8822018-02-0606 February 2018 NWMI-012 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Post-Hearing Questions ML18037B1162018-02-0606 February 2018 NRC-014 - NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018) ML18016A9642018-01-23023 January 2018 NWMI-004-R - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation ML18016A9592018-01-16016 January 2018 NWMI-001-R - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions ML18016A9622018-01-16016 January 2018 NWMI-003-R - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application ML18016A9662018-01-16016 January 2018 NWMI-005-R - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation ML18016A9692018-01-16016 January 2018 NWMI-006-R - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation ML18016A9712018-01-16016 January 2018 NWMI-007-R - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation ML18016A9572018-01-16016 January 2018 Nwmi List of Anticipated Witnesses (Revision 1) - Final ML18016B0712018-01-16016 January 2018 NRC-002 - Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (Revised Jan. 16, 2018) ML18016B0722018-01-16016 January 2018 NRC-003 - Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov. 17, 2017) (ADAMS Accession No. ML17313A338) (Revised Jan. 16, 2018) ML18016B0732018-01-16016 January 2018 NRC-004 - NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554) ML18016B0742018-01-16016 January 2018 NRC-010 - Staff Presentation Slides - Overview (Jan. 16, 2018) ML18016B0752018-01-16016 January 2018 NRC-011 - Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018) ML18016B0762018-01-16016 January 2018 NRC-012 - Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018) ML18016B0772018-01-16016 January 2018 NRC-013 - Staff Presentation Slides - Environmental Panel (Jan. 16, 2018) ML18016A9552018-01-16016 January 2018 Nwmi Commission Hearing Exhibit-R List - Final ML18002A4192018-01-0202 January 2018 NRC Staff Witness List ML18001A0012018-01-0101 January 2018 Exhibit List (Revised) of Northwest Medical Isotopes, LLC ML17363A4172017-12-29029 December 2017 Northwest Medical Isotopes, LLC List of Anticipated Witnesses ML17363A4132017-12-29029 December 2017 NWMI-007 - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation ML17363A4122017-12-29029 December 2017 NWMI-006 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation ML17363A4112017-12-29029 December 2017 NWMI-005 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation ML17363A4102017-12-29029 December 2017 NWMI-004 - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation ML17363A4092017-12-29029 December 2017 NWMI-003 - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application ML17363A4082017-12-29029 December 2017 NWMI-001 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions ML17363A2912017-12-29029 December 2017 Exhibit List of Northwest Medical Isotopes, LLC ML17363A4162017-12-18018 December 2017 NWMI-010 - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(f), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility, Dated December 18, 2017 ML17363A4142017-12-14014 December 2017 NWMI-008 - Federal, State of Missouri, City of Columbia, and Boone County Letters of Support for the Construction and Operation of the Northwest Medical Isotopes, LLC Radioisotope Production Facility ML18016B0982017-11-30030 November 2017 NRC-008 - Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as Revised Jan. 2018) ML18016B0702017-11-16016 November 2017 NRC-001 - SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037) ML18016B1092017-09-30030 September 2017 NRC-006B - Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (Psar), NWMI-2013-021, Rev. 3, Chapters 1 Through 2 (Sep. 2017) (ADAMS Accession Nos. ML17257A022 and ML17257A023) ML18016B1102017-09-30030 September 2017 NRC-006C - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A024) ML18016B1142017-09-30030 September 2017 NRC-006D - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025) ML18016B1152017-09-30030 September 2017 NRC-006E - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 Through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A ML18016B1172017-09-30030 September 2017 NRC-006F - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 Through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033) ML18016B1182017-09-30030 September 2017 NRC-006G - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 Through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257 ML17363A4152017-09-15015 September 2017 NWMI-009 - Clean Water Act Section 401 Water Quality Certification of Northwest Medical Isotopes, LLC Facility in Boone County, NUREG-2209/CEK007189 ML18016B0992017-05-31031 May 2017 NRC-009 - NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017) (ADAMS Accession No. ML17130A862) ML18016B1192015-06-30030 June 2015 NRC-006H - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, Beginning Through 19-130 (Jun. 2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131) ML18016B1202015-06-30030 June 2015 NRC-006I - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, 19-131 Through End (Jun. 2015) (ADAMS Accession Nos. ML15210A128 and ML15210A129) ML18016B1082015-02-15015 February 2015 NRC-006A - Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in Part)) 2018-02-06
[Table view] |
Text
NRC-013 Northwest Medical Isotopes Construction Permit Application Review
- Mandatory Hearing (Environmental Panel)
Panelists
- Chief, Environmental Review and NEPA Branch, NRR
- Physical Scientist, NRR
- Biologist, NRR
- Senior Project Manager, NRR 2 2
Environmental Review
- National Environmental Policy Act
- Environmental review process
- 10 CFR Part 51
- Interim Staff Guidance Augmenting NUREG-1537 for Licensing Radioisotope Production Facilities and Aqueous Homogenous Reactors 3
Scope of the Review: Proposed Action and Connected Actions Actions are connected if they:
- Automatically trigger other actions that may require environmental impact statements; or
- Cannot or will not proceed unless other actions are taken previously or simultaneously; or
- Are interdependent parts of a larger action and depend on the larger action for their justification 4
Proposed Action and Connected Actions
- Construction, operations, and decommissioning of the 10 CFR Part 50 production facility
- Construction, operations, and decommissioning related to target fabrication
- Transportation of targets to/from research reactors and irradiation of targets at research reactors 5
Environmental Impact Statement (EIS)
- Project-specific decision
- Operation of the proposed Northwest facility would include target fabrication and scrap recovery
- Environmental assessment might not support a finding of no significant impact 66
Scoping Process
- Eight comment letters or emails 77
Environmental Review Areas Air Quality Socioeconomics and Environmental Terrestrial Justice Resources Human Health Aquatic Resources Land Use Water Soils Resources Historic and Cultural Resources 8
Environmental Impacts Resource Area Impact Land Use and Visual Resources SMALL Air Quality and Noise SMALL Geologic Environment SMALL Ecological and Water Resources SMALL Historic and Cultural Resources SMALL Socioeconomics SMALL Human Health and Waste SMALL Transportation SMALL 9
Consultations Act Determination Endangered Species Act, No Effect Section 7 National Historic No Adverse Preservation Act, Effect Section 106 10
Alternatives
- Alternative technologies 11
Alternative Technologies
- Aqueous homogenous reactor
- Analyzed in depth
- Analyzed in depth 12
Costs and Benefits
- Inform recommendation to the Commission
- Environmental and financial
- Societal, medical, and economic 13
Draft Environmental Impact Statement
- Five comment letters or emails 14
Staff Conclusion and Recommendation
- Benefits (societal, medical, and economic) outweigh the costs (environmental, economic)
- Considered reasonable alternatives
- Recommend issuance of the construction permit 15
Future NEPA Analyses
- Application for an operating license
- License amendment requests from research reactors 16
Acronyms
- EIS - Environmental Impact Statement
- NEPA - National Environmental Policy Act
- NRR - Office of Nuclear Reactor Regulation 17